Market Overview

BTIG Sees Another Bidder For Cepheid 'Unlikely'

Share:
BTIG Sees Another Bidder For Cepheid 'Unlikely'

BTIG sees competing bids for Cepheid (NASDAQ: CPHD) unlikely following its deal to be acquired by Danaher Corporation (NYSE: DHR) for $53 a share in cash.

"Though the purchase price is essentially in line with CPHD's 52-week high ($53.19), we think its implied multiple of ~6x EV/NTM Sales is fair. We note that Cepheid's average EV/NTM Sales multiple is ~5.7x on a 10-year basis and ~6.1x on a five-year basis," analyst Karen Koski wrote in a note.

Koski also said there will be no anti-trust/Federal Trade Commission (FTC) issues over the deal given relatively limited product overlap.

Meanwhile, the analyst noted that Cepheid's senior leaders, engineers and sales people would need to be on board for Danaher to reap the benefits.

Related Link: Cepheid Announces FDA To Allow Expanded Claims For The Xpert TV Assay Urine Test

"Given DHR's organizational structure, we expect Cepheid to enjoy the necessary flexibility to operate independently, yet still benefit from R&D and commercial collaborations with DHR's other diagnostics businesses," Koski added.

Koski has downgraded Cepheid to Neutral following the takeover deal.

Shares of Cepheid closed Tuesday's regular trading at $52.53 and were flat on the day Wednesday at time of writing.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for CPHD

DateFirmActionFromTo
Sep 2016DowngradesOutperformNeutral
Sep 2016DowngradesBuyNeutral
Sep 2016MaintainsOutperform

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech M&A News Downgrades Health Care Price Target Analyst Ratings

 

Related Articles (CPHD + DHR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MSGNDowngrades
HUBBInitiates Coverage On160.0
CTREUpgrades25.0
GLNGMaintains27.0
SEMaintains45.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Worst Performing Industries For September 7, 2016

Stock Index Futures Little Lower